Latest Strategy News

Page 1242 of 1265
ENRG Elements Limited has renewed key uranium exploration permits in Niger and reported outstanding trenching assay results, while securing $2.2 million in new funding to advance its projects.
Maxwell Dee
Maxwell Dee
24 Jan 2025
InhaleRx has corrected its quarterly report and revealed a $38.5 million funding deal to fast-track clinical trials for its inhaled therapies targeting breakthrough cancer pain and panic disorder, aiming for FDA approval.
Ada Torres
Ada Torres
24 Jan 2025
8VI Holdings Limited has confirmed its voluntary delisting from the ASX, reporting a challenging quarter marked by declining cash reserves and a strategic pivot towards preventive care that is yet to yield significant revenue.
Ada Torres
Ada Torres
24 Jan 2025
Native Mineral Resources secures a conditional $6.5 million investment from entrepreneur Wes Maas, supporting its Queensland gold projects and targeting production restart in Q3 2025.
Maxwell Dee
Maxwell Dee
24 Jan 2025
Patagonia Lithium has withdrawn its previously announced 15-year, 10,000 tonnes per annum production target, clarifying it was aspirational and not compliant with ASX Listing Rules. This retraction raises questions about the project's near-term viability and investor confidence.
Maxwell Dee
Maxwell Dee
24 Jan 2025
Caspin Resources has completed its acquisition of the Bygoo Tin Project in NSW and is set to begin a significant drilling campaign, backed by a recent $1.6 million capital raise.
Maxwell Dee
Maxwell Dee
24 Jan 2025
Ten Sixty Four Limited has received a crucial US$10.5 million payment from Philsaga Mining Corporation, enabling it to settle outstanding related party debts and advance its Deed of Company Arrangement.
Maxwell Dee
Maxwell Dee
24 Jan 2025
Arafura Rare Earths Limited has acknowledged a breach of ASX Listing Rule 15.7 following premature media disclosure of a $200 million investment commitment from the National Reconstruction Fund Corporation. The company outlines corrective steps to prevent future compliance lapses.
Maxwell Dee
Maxwell Dee
24 Jan 2025
Alterity Therapeutics is poised to release topline data from its pivotal ATH434-201 Phase 2 trial in early-stage Multiple System Atrophy by February 2025, while managing a cash balance of A$4.54 million amid ongoing research expenses.
Ada Torres
Ada Torres
24 Jan 2025
Pacgold Limited reports promising high-grade gold anomalies from a major aircore drilling campaign at its Alice River Gold Project, alongside strategic board appointments and a successful Share Purchase Plan to fuel further exploration.
Maxwell Dee
Maxwell Dee
24 Jan 2025
Trinex Minerals has made significant progress at its Dudley Lithium Project on Kangaroo Island, securing key landowner agreements and completing a large soil sampling program that revealed multiple lithium anomalies. The company plans to commence drilling in March 2025, marking a pivotal step in its exploration strategy.
Maxwell Dee
Maxwell Dee
24 Jan 2025
Metrics Master Income Trust has announced an estimated unfranked dividend of AUD 0.0137 per unit, payable in February 2025, alongside a full Dividend Reinvestment Plan option.
Claire Turing
Claire Turing
24 Jan 2025